4//SEC Filing
Hawkinson Russ 4
Accession 0001209191-22-006444
CIK 0001671858other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:22 PM ET
Size
9.7 KB
Accession
0001209191-22-006444
Insider Transaction Report
Form 4
Hawkinson Russ
Sr. Vice President of Finance
Transactions
- Award
Stock Option (right to buy)
2022-02-01+45,000→ 45,000 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (45,000 underlying) - Award
Common Stock
2022-02-01+7,500→ 8,954 total - Award
Stock Option (right to buy)
2022-02-01+28,500→ 28,500 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (28,500 underlying)
Footnotes (4)
- [F1]The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 1,216 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2021.
- [F3]The shares subject to the option vest in equal monthly installments over the 48 months following February 1, 2022.
- [F4]25% of the shares subject to the option vest on February 1, 2023, and the remaining shares will vest monthly thereafter over three years.
Documents
Issuer
Silverback Therapeutics, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001831807
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:22 PM ET
- Size
- 9.7 KB